← Back

Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)

This grant supports research on the cellular, molecular and circuit mechanisms linked to high-confidence risk factors for complex brain disorders. It funds hypothesis-generating or hypothesis-testing studies using in vivo, in situ or in vitro models, including model organisms or human cell-based assays, to elucidate neurobiological impacts of individual or combined risk factors.

Amount
Not stated
Type
Grant

Key facts

Key facts for Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
AmountNot stated
IssuerNational Institutes of Health
Who can applySmall businesses, companies, universities and 7 more
SectorsHealthTech
DeadlineClosed 07 Sep 2026

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 40 days ago

  1. 85 days agoagentImported from the official source